46
CURRICULUM VITAE Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP PERSONAL INFORMATION Residence Address: 19347 Hickory Ridge Rd. Arcadia, Oklahoma 73007 Email: [email protected] Telephone: (405) 919-5128 Office Address: Physician Assistant Program Sarkeys Science and Math Center Oklahoma City University 2501 N. Blackwelder Avenue Oklahoma City, OK 73106 Email: [email protected] Phone: (405) 208-6263 Date of Birth: December 4, 1957 Place of Birth: Tuscaloosa, Alabama Family Status: Married - Nancy A. Letassy, August 11, 1984 Son - Cameron Jozef Britton, January 10, 1993 Licensure: Texas Pharmacy License #26179 Oklahoma Pharmacy License #10698 (preceptor, immunization permit) Board Certification: Certified Diabetes Educator #0941-6057 (since 1994) Advanced Diabetes Management #2006000593-45 (since 2006) EDUCATION Master of Divinity, Western Theological Seminary, Holland, Michigan, November 2006-August 2012 Residency in Ambulatory Care Pharmacy Practice, University of Texas at Austin, (Elaine Waller, Pharm.D., program director), July 1983-June 1984 Doctor of Pharmacy, University of Texas at Austin and the University of Texas Health Science Center at San Antonio, July 1981-June 1983 Bachelor of Science in Pharmacy, Summa Cum Laude, School of Pharmacy, Auburn University, Auburn, Alabama, January 1979-June 1981 Pre-pharmacy, University of Alabama, Tuscaloosa, Alabama, August 1975- December 1978

Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

  • Upload
    others

  • View
    7

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

CURRICULUM VITAE

Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP PERSONAL INFORMATION

Residence Address: 19347 Hickory Ridge Rd. Arcadia, Oklahoma 73007 Email: [email protected] Telephone: (405) 919-5128 Office Address: Physician Assistant Program

Sarkeys Science and Math Center Oklahoma City University 2501 N. Blackwelder Avenue Oklahoma City, OK 73106 Email: [email protected] Phone: (405) 208-6263

Date of Birth: December 4, 1957 Place of Birth: Tuscaloosa, Alabama Family Status: Married - Nancy A. Letassy, August 11, 1984 Son - Cameron Jozef Britton, January 10, 1993 Licensure: Texas Pharmacy License #26179 Oklahoma Pharmacy License #10698 (preceptor, immunization permit) Board Certification: Certified Diabetes Educator #0941-6057 (since 1994) Advanced Diabetes Management #2006000593-45 (since 2006)

EDUCATION

Master of Divinity, Western Theological Seminary, Holland, Michigan, November 2006-August 2012 Residency in Ambulatory Care Pharmacy Practice, University of Texas at Austin, (Elaine Waller, Pharm.D., program director), July 1983-June 1984 Doctor of Pharmacy, University of Texas at Austin and the University of Texas Health Science Center at San Antonio, July 1981-June 1983 Bachelor of Science in Pharmacy, Summa Cum Laude, School of Pharmacy, Auburn University, Auburn, Alabama, January 1979-June 1981 Pre-pharmacy, University of Alabama, Tuscaloosa, Alabama, August 1975-December 1978

Page 2: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2

PROFESSIONAL EXPERIENCE

Academic Assistant to the Provost for Health Professions and Clinical Professor, Oklahoma City University, Oklahoma City, Oklahoma, March 2019 to present Interim Program Director, Physician Assistant Program, Oklahoma City University, Oklahoma City, Oklahoma, July 2018-March 2019 Clinical Professor and Didactic Director, Physician Assistant Program, Oklahoma City University, Oklahoma City, Oklahoma, October 2016-February 2019 Senior Associate Dean for Academic Affairs and Professional Programs, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, July 2011-September 2016 (retired) Associate Dean for Academic Affairs, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, November 1999-June 2011 Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, July 2010-September 2016 (retired) Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, October 1995-June 2007, October 2008-June 2010 Director, ASHP-Accredited PGY2 Ambulatory Care Pharmacy Residency Program, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, July 1998-June 2009 Director, ASHP-Accredited PGY1 Residency Program, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, May 2004-June 2005 and December 2006-June 2007 Interim Vice-Chair for Clinical Service Development, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, January 1998-October 1999 Director of Ambulatory Care Programs, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, October 1995-November 1999

Director, ASHP-Accredited Primary Care Pharmacy Residency Program, College of Pharmacy, University of Oklahoma Health Sciences Center and Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, July 1993-June 1998 Clinical Associate Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, July 1995-September 1995, July 2007-September 2008

Page 3: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 3

Clinical Assistant Professor, Department of Pharmacy: Clinical and Administrative Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, January 1987-June 1995 Clinical Assistant Professor, Clinical Pharmacy Section, College of Pharmacy, University of Texas at Austin, July 1984-August 1986 Clinical Instructor, Clinical Pharmacy Section, College of Pharmacy, University of Texas at Austin, July 1983-June 1984 Graduate Teaching Assistant, Clinical Pharmacy Section, College of Pharmacy, University of Texas at Austin, July 1982-June 1983 Clinical Practice Director of Clinical Quality, Variety Care, Oklahoma City, Oklahoma, April 2019 to present Clinical Pharmacy Specialist, Variety Care Community Health Center, Oklahoma City, Oklahoma, December 2009-April 2016, April 2019 to present Clinical Pharmacy Specialist, Good Shepherd Ministries of Oklahoma, Oklahoma City, Oklahoma, October 2016 to present Pharmacotherapy Clinical Specialist, University of Oklahoma Family Medicine Center, Oklahoma City, Oklahoma, October 1995-September 2016

Lipid Research Pharmacist, Cardiology Section and Pharmacy Service, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, July 1998-March 2000 Clinical Coordinator, Pharmacy Service, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, September 1990-September 1995 Ambulatory Care Clinical Specialist, Pharmacy Service, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, May 1988-June 1998 Computer Coordinator, Department of Pharmacy, Oklahoma Medical Center, Oklahoma City, Oklahoma, June 1987-April 1988 Staff Pharmacist, Department of Pharmacy, Doctors General Hospital, Oklahoma City, Oklahoma, September 1986-December 1986 Pharmacist (part-time), Brackenridge Hospital, Austin, Texas, James Smeeding, Director of Pharmacy, August 1982-August 1984 Pharm.D. Resident, Medical Center Hospital Pharmacy, San Antonio, Texas, Carlos A. de la Garza, Director of Pharmacy, July 1981-June 1982

Page 4: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 4

TEACHING EXPERIENCE

ASHP-Accredited PGY2 Ambulatory Care Pharmacy Residency Program Director for the following residents from July 1993-June 2009:

Teresa Nguyen, Pharm.D. (July 2008-June 2009) Jennifer Bird, Pharm.D. (July 2005-June 2006) Todd Marcy, Pharm.D. (July 2003-June 2004) Amy J. Parker, Pharm.D. (July 2001-June 2002) David B. Hughes, Pharm.D. (July 2001-June 2002) Stephanie Anderson, Pharm.D. (July 2000-June 2001) Carrie Marvin Nichols, Pharm.D. (July 2000-June 2001) Edna Patatanian, Pharm.D. (July 2000-June 2001) Randall Sharp, Pharm.D. (July 2000-June 2001) Adam Gregg, Pharm.D. (July 1999-June 2000) Kimberly Hope, Pharm.D. (July 1999-June 2000) Hengameh Lavasanifar, Pharm.D. (July 1999-June 2000) Kristina Alford Giometti, Pharm.D. (July 1998-June 1999) Becky Anderson Armor, Pharm.D. (July 1998-June 1999) Steven M. Boatright, Pharm.D. (July 1998-June 1999) Kelly J. Swensgard, Pharm.D. (July 1998-June 1999) Hoan Linh Banh, Pharm.D. (July 1997-June 1998) Mary Ann Halloran, Pharm.D. (July 1997-June 1998) Diane Laatsch Erdman, Pharm.D. (July 1997-June 1998) Kenneth McCall, Pharm.D. (July 1997-June 1998) Carmella Foster, Pharm.D. (July 1996-June 1997) Suzanne A. Reynolds, Pharm.D. (July 1996-June 1997) Travis E. Watts, Pharm.D. (July 1995-June 1996) Vincent C. Dennis, Pharm.D. (July 1995-June 1996) Jacques P. Landry, Pharm.D. (July 1994-June 1995) Joni K. Beck, Pharm.D. (July 1993-June 1994) C. Denise Howard, Pharm.D. (July 1993-June 1994)

Primary Care Fellowship Director, 2002-2003

David Hughes, Pharm.D. (July 2002-June 2003)

ASHP-Accredited PGY1 Pharmacy Residency Program Program Director, July 2004-June 2005 and December 2006-July 2007 for the

following residents: Matthew Bird (July 2006-June 2007) Emily Borders (July 2006-June 2007) Kaysey Cloud (July 2006-June 2007) Jessica Cottreau (July 2006-June 2007) Jamie Miller (July 2006-June 2007) Shaunta Martina (July 2004-June 2005) Tamara Mlekoday (July 2004-June 2005) Erica Smith (July 2004-June 2005) Dena Stout (July 2004-June 2005)

Page 5: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 5

Tracy Watson (July 2004-June 2005) Traineeships for Health Care Professionals Director and Instructor June 1993-2006

ASHP Diabetes Patient Care Traineeship for Pharmacists, sponsored once annually by the Foundation of the American Society of Health-System Pharmacists and earned through competition, educated 14 pharmacists at the University of Oklahoma Family Medicine Center Pharmacotherapy Service, Oklahoma City, Oklahoma, 2002-2006 Lipid Training Program for Health Care Professionals; continuing education certificate program; educated over 250 pharmacists, nurse practitioners, dietitians, and physicians assistants; sponsored several times annually by the University of Oklahoma College of Pharmacy Continuing Education Division; Oklahoma City, Oklahoma, 1994-2001 National Lipid Training Center for Pharmacists, sponsored twice by the National Pharmacy Cholesterol Council and earned through competition, educated 6 pharmacists at the Oklahoma City Department of Veterans Affairs, Oklahoma City, Oklahoma, 1993

Oklahoma City University Oklahoma City, Oklahoma 2016 to present

Professional (Physician Assistant) PA 5116 Introduction to Human Form (course coordinator) PA 5131 Hematology-Genetics (lecturer) PA 5154 Cardiology (lecturer) PA 5161 Geriatrics (course coordinator) PA 5213 Urinary System (lecturer) PA 5232 Endocrinology (lecturer) PA 5252 Behavioral Health (course coordinator) PA 5383 Capstone (course coordinator)

University of Oklahoma College of Pharmacy Oklahoma City, Oklahoma 1987-2016

Professional (Doctor of Pharmacy Program)

PHAR 4442 Introduction to Toxicology (lecturer) PHAR 4802 Pharmacotherapeutics I (lecturer) PHAR 4804 Pharmacotherapeutics II (lecturer) PHAR 4812 Nonprescription Products I (lecturer) PHAR 4822 Nonprescription Products II (lecturer) PHAR 4993 Pharmacy Capstone Seminar (developer, coordinator) PHAR 5033 Clinical Clerkship in Ambulatory Care (coordinator) PHAR 5822 Drugs in Therapy (lecturer) PHAR 5843 Pharmacy Practice Laboratory (developer, coordinator)

Page 6: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 6

PHAR 5990 Special Studies in Pharmaceutical Sciences (coordinator) PHAR 7021 Pharmacy Practice II (lecturer) PHAR 7024 Ambulatory Care Practicum (as a member of a team) PHAR 7030 Ambulatory Care Practicum (as a member of a team) PHAR 7094 Selective Pharmacy Practice (as a member of a team, when

offered) PHAR 7162 Nonprescription Products I (lecturer) PHAR 7523 Clinical Toxicology (lecturer) PHAR 7543 Advanced Diabetes Care (lecturer, lab facilitator) PHAR 7702 Pharmacy Practice Management (lecturer) PHAR 7732 Pharmacy Law and Ethics (lecturer, facilitator) PHAR 7733 Clinical Communications (lecturer, lab facilitator) PHAR 7772 Introduction to Ambulatory Care (lecturer, facilitator) PHAR 7800 Advanced Pharmacotherapeutics I (lecturer) PHAR 7810 Advanced Pharmacotherapeutics II (lecturer) PHAR 7824 Pharmaceutical Care II: Cardiovascular Disease (developer,

coordinator) PHAR 7827 Advanced Pharmacotherapeutics I (lecturer) PHAR 7832 Advanced Pharmacokinetics II (lecturer) PHAR 7833 Pharmaceutical Care III: Respiratory and Renal Diseases

(lecturer) PHAR 7853 Pharmaceutical Care V: Endocrine Diseases (lecturer, TBL

facilitator) PHAR 7883 Pharmaceutical Care VIII: Hematology-Oncology (lecturer) PHAR 7891 Pharmaceutical Care IX: Dermatology (lecturer) PHAR 7980 Research in Pharmacy Practice (coordinator, when offered) PHAR 7990 Independent Study (coordinator, when offered) PHAR 8100 Spirituality in Medicine (developer)

Post-Professional (PGY1 and PGY2 Residency Programs)

Resident Rounds (facilitator, for all PGY1 and PGY2 residents) Ambulatory Care Rounds (facilitator, for PGY1 community pharmacy

residents and PGY2 ambulatory care residents)

University of Oklahoma College of Medicine Oklahoma City, Oklahoma 1990-2016

Fourth Year Medical Students

Principles of Drug Therapy in Geriatric Patients (lecturer) Physician Associate Programs (Oklahoma City and Tulsa campuses)

PA 7004 Focus in PA Medicine (lecturer) PA 7105 Pharmacotherapeutics (course coordinator, lecturer) PAT 7105 Pharmacotherapeutics (course coordinator, lecturer)

(Oklahoma City’s PA 7103 and Tulsa’s PAT 7105, delivered simultaneously to Oklahoma City and Tulsa using distance education technologies)

Page 7: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 7

University of Oklahoma College of Nursing Oklahoma City, Oklahoma 2000-2002

Nurse Practitioner Program

PHSC 5010 Pharmacotherapeutics (lecturer) University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma Interprofessional Education Programs 2013-2016

EPIC (Empowering Patients through Interprofessional Collaboration) Program (September through April 2013-2016)

Teams and Teamwork (lecturer and facilitator) Good Shepherd Clinic experiential component (clinic preceptor)

All Professions Days (October 30, 2015 and January 28, 2016)

Teams and Teamwork (lecturer and facilitator)

Oklahoma State University College of Osteopathic Medicine Tulsa, Oklahoma 1990-1991

Third Year Osteopathic Students

Principles of Drug Therapy in Geriatric Patients (lecturer) University of Texas College of Pharmacy Austin, Texas 1982-1986

Undergraduate

PHR 266P Prescription Dispensing Laboratory (facilitator) PHR 366L Disease Processes and Therapeutic Management (lecturer) PHR 366T Clinical Pharmacy Clerkship in Ambulatory Care (coordinator) PHR 366T Clinical Pharmacy Clerkship in Internal Medicine (coordinator) PHR 366T Clinical Pharmacy Clerkship in Drug Information (coordinator) PHR 366T Clinical Pharmacy Case Conference (facilitator)

Graduate

Preceptor of second year Doctor of Pharmacy students on required ambulatory care and internal medicine clinical rotations

Clinical Pharmacy Programs College of Pharmacy

Page 8: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 8

The University of Texas Health Sciences Center San Antonio, Texas 1984-1986

Graduate

PHR 189E Advanced Therapeutics of Musculoskeletal Diseases (lecturer) PHR 189H Advanced Therapeutics of Gastrointestinal Diseases (lecturer) PHR 289J Advanced Therapeutics of Cardiovascular Diseases (lecturer)

Internal Medicine Residency Program Central Texas Medical Foundation Brackenridge Hospital Austin, Texas 1984-1986

Preceptor for second and third year internal medicine residents on an elective clinical pharmacology and pharmacokinetics rotation

PUBLICATIONS

Journal Articles Thompson BM, Bratzler DW, Fisher MJ, Torres A, EPIC Faculty (Britton ML, Dennis VC, Letassy NA, Dmytryk J, Jones R, Ferretti M, Johnson C, Barbee C, Bender D, Fritz T, Miller CR, Goldson L, Kinney S, Loving G, Craft M, Wilcox J, Reinhardt L, McNeill DL, Wisdom PJ), Sparks RA. Working Together: Using a Unique Approach to Evaluate an Interactive and Clinc-based Longitudinal Interprofessional Education Experience with 13 Professions. Journal of Interprofessional Care. 2016;30(6):754-761. Letassy NA, Medina MS, Dennis VC, Draugalis JL, Britton ML. A Progressive, Collaborative Process to Improve a Curriculum and Define and Assessment Program. American Journal of Pharmaceutical Education. 2015;79(4):article 55. Dennis VC, Britton ML, Wheeler RE, Carter SM. Practice Experiences at a Single Institutional Practice Site to Improve Advanced Pharmacy Practice Examination Performance. American Journal of Pharmaceutical Education. 2014;78(3):article 60. Medina MS, Britton ML, Letassy NA, Dennis VC, Draugalis JR. Incremental Development of an Integrated Assessment Method for the Professional Curriculum. American Journal of Pharmaceutical Education. 2013;77(6):article 122. Edwards HD, Webb RD, Scheid DC, Britton ML, Armor BL. A Pharmacist Visit Improves Diabetes Standards in a Patient-Centered Medical Home (PCMH). American Journal of Medical Quality. 2012;27(6):529-34. Bird ML, Dunn RL, Hagemann TM, Burton ME, Britton ML, St. Cyr MB. Successful Collaboration between a College of Pharmacy and a For-Profit Health-System at an

Page 9: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 9

Academic Medical Center. American Journal of Health-System Pharmacy. 2012;69(1):1150-6. Conway SE, Medina MS, Letassy NA, Britton ML. Assessment of Streams of Knowledge, Skill, and Attitude Development Across the Doctor of Pharmacy Curriculum. American Journal of Pharmaceutical Education. 2011;75(5):article 83. Truong, TH, Britton ML, Harrison DL, Letassy NA, Armor BL, Tonemah D, Nguyen A. Assessing the Need for Diabetes Self-Management Education in the Oklahoma City Vietnamese Community. Diabetes Therapy. 2011;2(2):DOI 10.1007/s13300-010-0020-6. Marcy, TR, Britton ML, Harrison DL. Identification of Barriers to Appropriate Dietary Behavior in Indigent Patients with Type 2. Diabetes Therapy. 2011;1(2):DOI 10.1007/s13300-010-0012-6. Armor BL, Britton ML, Dennis VC, Letassy NA. A Review of Pharmacist Contributions to Diabetes Care in the United States. Journal of Pharmacy Practice. 2009, DOI:10.1177/0897190009336668. Letassy NA, Medina MS, Stroup J, Fugate S, Britton ML. Using Team-Based Learning in an Endocrine Module across Two Campuses. American Journal of Pharmaceutical Education. 2008;72(5):article 103. Britton ML, Letassy NA, Medina MS, Er N. A Curriculum Review and Mapping Process Supported by an Electronic Data Basing System. American Journal of Pharmaceutical Education. 2008;72(5):article 99. Medina M, Medina P, Wanzer D, Wilson J, Er N, Britton ML. The Use of an Audience Response System (ARS) in a Multipoint Classroom Environment. American Journal of Pharmaceutical Education. 2008;72(2):article 38. Campbell J, Blank K, Britton ML. Experiences with an Elective in Spirituality. American Journal of Pharmaceutical Education. 2008;72(1):article 16. Hughes DB, Britton ML. Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers for Prevention and Treatment of Nephropathy Associated with Type 2 Diabetes. Pharmacotherapy. 2005;25:1602-20. Marcy TR, Britton ML. Antidepressant-Induced Sweating. Annals of Pharmacotherapy. 2005;39:748-52. Marcy TR, Britton ML, Blevin SM. Second-Generation Thiazolidinediones and Hepatotoxicity. Annals of Pharmacotherapy. 2004;38:1419-23. Armor BL, Britton ML. Diabetes Mellitus Non-Glucose Monitoring: Point-of-Care Testing. Annals of Pharmacotherapy. 2004;38:1039-47. Letassy NA, Armor BL, Britton ML. Pharmacist-Managed Diabetes Service in a Family Medicine Practice Improves Patient Outcomes. Drug Benefit Trends. 2003;15(Suppl H):21-32.

Page 10: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 10

Freeman DA, Britton ML, Letassy NA, Sirmans SM, Neal AVA, Beck J. Management of Hyperlipidemia in a Clinical Pathway Unit. Disease Management. 1998;1:111-20. Britton ML, Bradberry JC, Letassy NA, McKenney JM, Sirmans SM. ASHP Therapeutic Position Statement on the Safe Use of Niacin in the Management of Dyslipidemias. American Journal of Health-System Pharmacy. 1997;54:2815-9. Dennis VC, Britton ML, Sirmans SM, Letassy NA, Freeman DA. The Use of Alternate Day Lovastatin in Hypercholesterolemic Males. Pharmacotherapy. 1997;31:708-12. Britton ML, Letassy NA, Sirmans SM. Managing High Blood Cholesterol in Patients with Coronary Artery Disease. Pharmacy Times. 1994;60:64-70. Britton ML, Lobeck FG, Kelly MW. A Multidisciplinary Committee to Address the Abuse of Prescription Medication. American Journal of Hospital Pharmacy. 1994;51:85-8. Britton ML, Letassy NA, Sirmans SM, Neal AVA, Freeman DA. An Interdisciplinary Lipid Clinic. VA Practitioner. 1993:10:63-5. Britton ML, Lurvey PL. Impact of Medication Profile Review on Prescribing in a General Medicine Clinic. American Journal of Hospital Pharmacy. 1991;48:265-70. Letassy NA, Thompson DF, Britton ML, Suda RR. Nafarelin: A Gonadotropin-Releasing Hormone Agonist for the Treatment of Endometriosis. DICP: The Annals of Pharmacotherapy. 1990;24:1204-9. Britton ML, Waller ES. Central Nervous System Toxicity Associated with Concurrent Use of Triazolam and Cimetidine. Drug Intelligence and Clinical Pharmacy. 1985;19(9):666-8. Electronic Publication Britton ML as a member of the ASTHO Oklahoma Million Hearts Learning Collaborative, “Million Hearts Case Study: Oklahoma Improves Hypertension Identification and Control through Care Coordination and Payer Partnerships’” in Association of State and Territorial Health Officials (ASTHO) newsletter (March 28, 2016). http://www.astho.org/Prevention/Chronic-Disease/Million-Hearts/Million-Hearts-Systems-Change-Case-Study--Oklahoma/ Britton ML, “University of Oklahoma College of Pharmacy – Integrating Pharmacists into the Delivery of Primary Care” in Progress and Promise: Profiles in Interprofessional Health Training to Deliver Patient-Centered Primary Care, Patient-Centered Primary Care Collaborative (December 2014). https://www.pcpcc.org/download/5401/PCPCC_EandT_Final.pdf?redirect=node/201964

Page 11: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 11

Medina MS, Britton ML, Smith WJ. AACP Successful Practices: Residency Training as a Foundation for Faculty Preparation. AACP E-Lert (May 29, 2009). http://www.aacp.org/resources/education/Pages/SuccessfulPracticesinPharmaceuticalEducation.aspx Chapter in a Book Britton ML. Physician Survey. In: Blair MM, ed. ACCP Ambulatory Care New Practitioners Survival Guide/Resource Manual. Lenexa, KS: American College of Clinical Pharmacy;2008:8-10. Britton ML. Physician Survey. In: Blair MM, Blake EW, Harris IM, eds. Ambulatory Care Survival Guide. Kansas City, MO: American College of Clinical Pharmacy;2004:11-3. Teaching Modules Letassy NA, Britton ML. Diabetic Dyslipidemia. A clinical case study developed for the continuing education program, "Developing Basic Skills and Knowledge Base to Provide Pharmaceutical Care in a Rapidly Changing Health Care Arena: A Program for VA Staff Pharmacists,” sponsored by the University of Tennessee College of Pharmacy, Memphis Department of Veterans Affairs, and CibaGeneva Pharmaceuticals and conducted in Memphis, Tennessee on January 5-7, January 26-28, and February 23-25, 1996 Britton ML, Letassy NA, Sirmans SM. Heart Disease Regression: Truth or Consequences. A continuing education program for pharmacists developed for the St. Louis University College of Pharmacy, 1995. Britton ML, Cohen LJ, Winn P. Polypharmacy in the Elderly: An Interdisciplinary Geriatric Teaching Module. Oklahoma Geriatric Education Center, 1991. Allen ME, Belzer JA, Bernard M, Britton M, Calvert JC, Carney J, Cohen L, Greer M, Harned TL, Kamp MM, Mold JW, Muret CT, Robinson C, Root J, Schmitt E. Falls in the Elderly: An Interdisciplinary Geriatric Teaching Module. Oklahoma Geriatric Education Center, 1990. Pharmacy Abstracting Services Thompson DF, Britton ML. Drug Consult: Nicotinic Acid – Reactivation of Peptic Ulcer. In: Gelman CR, Rumack BH, eds. Drugdex Information System, 46th Edition. Denver: Micromedex, Inc., 1989. Thompson DF, Britton ML. Drug Consult: Verapamil – Incidence of Constipation. In: Gelman CR, Rumack BH, eds. Drugdex Information System, 46th Edition. Denver: Micromedex, Inc., 1989. Thompson DF, Britton ML. Drug Consult: Warfarin – Effect on Activated Partial Thromboplastin Time. In: Gelman CR, Rumack BH, eds. Drugdex, 44th Edition. Denver: Micromedex, Inc., 1989.

Page 12: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 12

Knodel L, Britton ML, Crow J. Drug Consult: Penicillin G – Dialyzability. In: Conner C, ed. Drugdex, 28th Edition. Denver: Micromedex, Inc., 1985. Knodel L, Britton ML, Crow J. Drug Consult: Anaphylaxis – Treatment in Patients Receiving Propranolol. In: Connor C, ed. Drugdex, 28th Edition. Denver: Micromedex, Inc., 1985. Knodel L, Britton ML, Crow J. Drug Consult: Fenfluramine Therapy for Weight Reduction in Diabetic Patients. In: Conner C, ed. Drugdex, 28th Edition. Denver: Micromedex, Inc., 1985. Videotapes and Other Recordings Warning B, Britton ML. “Stories from the Nexus: Podcast Series Explores Interprofessional Training in Primary Care, Chapter 3 (https://nexusipe.org/progress-and-promise-podcast-series),” Patient-Centered Primary Care Collaborative, April 2015. Superko R, Britton ML. "Empiric Pharmacotherapy for Cardiovascular Risk: Morally Correct, Medically Sound, and Cost Effective," Back East Productions for the Upjohn Company, September 1995. Written Work Included in Educational Materials of Professional Organizations An excerpt from a transcript of my presentation “Current Trends in Managing Dyslipidemia in Adults with Diabetes: Management of Diabetic Dyslipidemias in a VA Lipid Clinic,” an active learning session delivered at the ASHP Annual Meeting in June 1998 in Baltimore, Maryland was requested for inclusion on pp. 11-12 of the ASHP on-line publication “How Will We Get There?: Instructional Strategies,” part 2 of a 4 part series entitled “First Class Continuing Pharmacy Education,” accessible at http://www.ashp.org/s_ashp/docs/files/CE/Part_2_Instructional_Strategies.pdf (accessed Nov. 3, 2009) Excerpts from my final edited version of the University of Oklahoma Professional Program Accreditation Self-Study Report of November 2005 are included as exemplary models in the training materials used by the Accreditation Council for Pharmacy Education for individuals preparing to be members of accreditation site visit teams (permission given on February 2007 to use these materials)

CREATIVE ACHIEVEMENT AND RESEARCH ACTIVITY

Training Completed all requirements to conduct human subjects research at the University of Oklahoma Health Sciences Center, March 2001 and updated annually

Funded Grants Received as Principal Investigator Britton ML, Letassy NA. Development of Team-Based Experiential Education Rotations for Foot Care and Dental care of Patients with Diabetes at a Primary Care Practice Site, funded by the Wisdom Family Foundation, $164,500, February 2015-August 2016

Page 13: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 13

Britton ML, Letassy NA, Carter SM. Evaluation of an Assessment Method for Health Professional Students Completing an Inter-Professional Curriculum Focused on Team-Based Care of Patients with Diabetes Mellitus, funded by the Wisdom Family Foundation, $139,000, January 2013-June 2015 Britton ML, Letassy NA, Armor BL, Dennis VC, Marcy TR, Barud S, Hall M. Educational Grant to Develop a Diabetes Traineeship, funded by the American Society of Health-System Pharmacists Foundation, $2500, June 2006 Britton ML, Letassy NA, Armor BL, Dennis VC, Marcy TR, Chonlahan J, Beach P. Educational Grant to Develop a Diabetes Traineeship, funded by the American Society of Health-System Pharmacists Foundation, $2500, June 2005 Britton ML, Letassy NA, Halloran MA, Dennis VC, Armor BL. Educational Grant to Develop a Diabetes Traineeship, funded by the American Society of Health-System Pharmacists Foundation, $5000, June 2004 Britton ML, Letassy NA, Halloran MA, Dennis VC, Armor BL. Educational Grant to Develop a Diabetes Traineeship, funded by the American Society of Health-System Pharmacists Foundation, $5000, June 2003 Britton ML, Letassy NA, Halloran MA, Dennis V. Educational Grant to Develop a Diabetes Traineeship, funded by the American Society of Health-System Pharmacists Foundation, $5000, May 2002 Britton ML, Letassy NA, Havrda D, Counts S, Halloran MA, Feuge R. Educational Grant to Develop a Lipid Therapy Seminar and Lipid Training Program for Pharmacists, funded by Merck and Company, Inc., $30,000, March 2001 Britton ML, Letassy NA, Havrda D, Counts S, Halloran MA, Feuge, R. Educational Grant to Develop a Lipid Therapy Seminar and Lipid Training Program for Pharmacists, funded by Merck and Company, Inc., $30,000, April-October 2000 Britton ML, Letassy NA, Sirmans SM, Beck JS. Educational Grant to Develop a Lipid Training Program for Pharmacists, funded by Merck and Company, Inc., $30,000, January-February 1998 Britton ML, Letassy NA, Sirmans SM, Beck JS. Educational Grant to Develop a Lipid Training Program for Pharmacists, funded by Merck and Company, Inc., $30,000, June-November 1997 Britton ML, Letassy NA, Sirmans SM, Beck JS. Educational Grant to Develop a Lipid Training Center for Pharmacists, funded by Pharmacia and Upjohn, $37,800, April-September 1997 Britton ML, Letassy NA, Sirmans SM. Educational Grant to Develop a Lipid Training Center for Pharmacists, funded by the Upjohn Co., $63,000, March-November 1996

Page 14: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 14

Britton ML, Letassy NA, Sirmans SM. Educational Grant to Evaluate the Impact on Cost and Quality of Lipid Disorders Treated by Pharmacists, funded by the Upjohn Co., $3000, March 1995 Britton ML, Letassy NA, Sirmans SM. Educational Grant to Develop a Lipid Training Center for Pharmacists, funded by the Upjohn Co., $60,000, November 1994-November 1995 Britton ML, Letassy NA, Sirmans SM, Larson LN, Freeman DA. Pharmacoeconomic Analysis of a Pharmacist Managed Lipid Clinic, an educational grant provided by Merck, $10,000, 1994 Britton ML, Letassy NA, Sirmans SM. Developmental Grant to Establish a National Training Center for Pharmacist Managed Lipid Clinics, funded by the National Pharmacy Cholesterol Council and Bristol-Myers Squibb Co., $21,000, 1993 Britton ML, Letassy NA, Freeman DA, Lurvey PL. An Evaluation of the Effects on Drug Therapy and Blood Pressure Control of Hypertension Clinic Patients Resulting from the Collaboration of Clinical Pharmacists with a Physician Assistant in a Department of Veterans Affairs Medical Center, funded by the Upjohn Company, $1375, 1991-2 Britton ML, Letassy NA, Freeman DA, Lurvey PL, Crawley C. Practitioner Response at a Department of Veterans Affairs Medical Center to High Blood Cholesterol Levels Following the Establishment of the National Cholesterol Education Program Guidelines, funded by the Upjohn Company, $1375, 1991-2 Funded Grants Received as a Co-Investigator Fisher MJ, Thompson B, Sparks R, Britton ML, Dennis V, Letassy NL, Blevins S, Reinhardt L, Ferretti M, Turner P, Loving G, Bratzler D, Dmytryk J, Jones R, Miller C, Fritz T, Johnson C. Empowering Patients through Interprofessional Collaboration (EPIC), Wisdom Family Foundation, $150,000, August 2012-June 2015 Lurvey PL, Bradberry JC, Britton ML. A National Conference on Pharmacy Practice Experiential Laboratories: Future Directions, Methods, and Resources, funded by Grants Awards for Pharmacy Schools (GAPS), American Association of Colleges of Pharmacy, $15,000, 1989-90 Grants Submitted as a Co-Investigator Hsieh E (principal investigator), Brashers DE, Britton ML (co-investigator), Letassy NA, Rintimaki LS, Wright KB, Zubialde J. Situating Health Literacy and Social Support in the Management of Diabetes (R01 HS016349-01), National Institutes of Health and Agency for Healthcare Research and Quality, $902,576 (submitted October 2006, not funded) Johnson DL (principal investigator), Dmytryk JJ, Seaman JS, Burton ME, Britton ML, Pfefferbaum B, Vincent R. Bioterrorism Training and Curriculum Development Program, Department of Health and Human Services Health Resources and Service Administration Grant, submitted May 2005 (not funded)

Page 15: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 15

DeHart RL, Lawler F, Schweibert P, Britton ML, Hamm R, Viviani N, Jones A. Establishment of a Diabetes Care Service, Department of Health and Human Services Establishment of Departments of Family Medicine Program, resubmitted February 1999 (not funded) McLeroy KR, Esmen NA, Go OT, Johnson DL, Knehans A, McFall SL, Narine L, Buckner CK, Reinke LA, Sachdev GP, Britton ML, Counts S, Smith DW, Yeh J, Cummings RD, Dunn ST. Centers for Children’s Environmental Health and Disease Prevention, National Institute of Environmental Health Sciences, $210,602, submitted January 1998 (not funded) DeHart RL, Lawler F, Schweibert P, Britton ML, Hamm R, Viviani N, Jones A. Establishment of a Diabetes Care Service, Department of Health and Human Services Establishment of Departments of Family Medicine Program, submitted February 1997 (approved, not funded) Freeman DA, Britton ML, Neal AVA, Kashner TM, Willis LO. Evaluation of a Cardiovascular Risk Reduction Unit, Health Services Research and Development, Department of Veterans Affairs, submitted July 1993 (not funded) Contract Research Whitsett T (principal investigator), Havrda D, Hawk T, Letassy N, Dennis V, Britton ML (sub-investigator), “Efficacy and Safety Study of the Oral Direct Thrombin Inhibitor H 376/95 Compared with Dose-Adjusted Warfarin (Coumadin®) in the Prevention of Stroke and Systemic Embolic Events in Patients in Patients with Atrial Fibrillation (SPORTIF V), Protocol #233 (SH-TPA-0005), April 2001-February 2002 Kem DC (principal investigator), Britton ML (co-principal investigator), Havrda D, Letassy NA, Counts S, Feuge R, Halloran M, Dennis J, Hawk T. Participating as a site in the study entitled “Clinical protocol for a double-blind, randomized comparison of eplerenone and losartan in patients with low rennin hypertension,” G.D. Searle & Co. Study IE3-99-02-019, $3460 per patient enrolled, July 2000-October 2000 (study closed as a cost efficiency by Searle before patients could be enrolled) Kem DC (principal investigator), Britton ML (co-principal investigator), Havrda D, Letassy NA, Counts S, Feuge R, Halloran M, Dennis J, Hawk T. Participating as a site in the study entitled “Clinical protocol for a double-blind, controlled, randomized comparison study of the antihypertensive effect of eplerenone and spironolactone in patients with hypertension secondary to primary aldosteronism,” G.D. Searle & Co. Study IE3-99-02-018, $2815 per patient enrolled, July 2000-October 2000 (study closed as a cost efficiency by Searle before patients could be enrolled) Comp P (principal investigator), Havrda D, Letassy N, Counts S, Feuge R, Halloran M, Britton ML (sub-investigator), “PREVENT: Prevention of Recurrent Venous Thromboembolism,” National Heart Lung and Blood Institute Protocol #HL58036, $1100 per patient enrolled, November 1999-September 2004 Kem DC (principal investigator), Britton ML (co-principal investigator), Havrda D, Letassy NA, Counts S, Feuge R, Halloran M, Beck J. Participating as a site in the study entitled “A 20-week, double-blind, randomized, active-controlled, multicenter

Page 16: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 16

study comparing efficacy and safety of troglitazone plus metformin or rosiglitazone plus metformin to metformin plus placebo in type 2 diabetic patients not optimally controlled on metformin,” Parke-Davis protocol 991-241, $2,670 per patient enrolled, October 1999-March 2000 (study closed before patients were enrolled due to troglitazone’s withdrawal from the market) Kem DC (principal investigator), Britton ML (co-principal investigator), Havrda D, Letassy NA, Counts S, Beck J. Participating as a site in the study entitled “A 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-group, Multicenter study to Evaluate Troglitazone (CI-991) plus Metformin in Early Stage type 2 Diabetic Patients,” Parke-Davis protocol 991-148, $35,800, October 1998-April 1999 Kugelmass A (principal investigator), Beck JK, Britton ML (subinvestigator), Letassy NA, Havrda DM, Freeman DA, Rathbun SW. Participating as a site in the international study entitled “The Effect of LDL-Cholesterol Lowering Beyond Currently Recommended Minimum Targets on Coronary Heart Disease Recurrence in Patients with Pre-existing Coronary Heart Disease” (also known as the “TNT Trial”), Parke-Davis protocol #981-117 and Pfizer protocol 258-102, $101,000 plus recruitment bonuses, June 1998-March 2000 Freeman DA (principal investigator), Sirmans SM, Letassy NA, Beck JS, Britton ML (subinvestigator). Participating as a site in the multicenter study entitled “A 54-Week Open Label Assessment of the Safety and Efficacy Profile of Atorvastatin as Compared to Fluvastatin, Lovastatin, Simvastatin, and Pravastatin when Used to Optimally Control Primary Hypercholesterolemia (Type IIA) and Mixed Dyslipidemia (type IIB),” Parke-Davis Protocol #981-176 and Pfizer Protocol #258-101, $67,200, April 1997-December 1998 Fellow and Resident Project Research Supervision and Collaboration Nguyen T, Britton ML, Tonemah D, Harrison D, Letassy NA. A Pilot Needs Assessment for Diabetes Self-Management Education in the Vietnamese Community of the Oklahoma City Metropolitan Area. Conducted at primary care offices of physicians primarily treating Vietnamese patients in and around Oklahoma City, July 2008-December 2010 Bird J, Britton ML, Marcy T, Barud S, Harrison D, Lawler F, Scheid D. Evaluation of the Process of Care for Diabetic Patients with Chronic Kidney Disease in a Primary Care Setting. Conducted at the University of Oklahoma Family Medicine Center, July 2005-June 2006 Marcy T, Beach P, Hughes DB, Britton ML. Identification of Barriers to Appropriate Dietary Behavior and Evaluation of Their Relative Importance in Oklahoma Medicaid Patients with Type 2 Diabetes Mellitus Followed in a Diabetes Co-Management Service Staffed by Pharmacists and a Dietitian. Conducted at the University of Oklahoma Family Medicine Center, December 2003-May 2005 Hughes DB, Britton ML, Letassy NA, Dennis VC, Armor B. The Evaluation of the Impact of a Diabetes Co-Management Service on the Care of Diabetic Patients in a Primary Care Clinic: A Retrospective Chart Review. Conducted at the University of Oklahoma Family Medicine Center, July 2002-June 2003

Page 17: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 17

Sharp R, Britton ML. Survey of Family Medicine Physicians’ Receptivity and Attitudes Towards Primary Care Pharmacists. Conducted at the University of Oklahoma Family Medicine Center, October 2000-June 2001 Gregg A, Britton ML, Beck J, Kugelmass A. Evaluation of the Offset Time of Lipid-modifying Effects of HMG CoA Reductase Inhibitors. Conducted using data from the Oklahoma City VA Medical Center Lipid Clinic, July 1999-June 2000 Anderson B, Britton ML. Development of a Diabetes Management Service in a Family Medicine Center. Conducted at the University of Oklahoma Family Medicine Center, May 1997-April 1998 McCall K, Britton ML. An Assessment of the Management of Anticoagulant Therapy by Physicians, Residents, and Physician Associates in the University of Oklahoma Family Medicine Center. Conducted at the University of Oklahoma Family Medicine Center, May 1996-March 1997 Foster CL, Letassy NA, Olansky L, Bohlman G, Higgens B, Schwake C, Britton ML. Evaluation of the Effect of a Group Diabetes Education Program on Glycemic control in Diabetic Patients as Measured by Changes in Fructosamine Levels. Conducted at the Oklahoma City Department of Veterans Affairs Medical Center, January 1995-June 1996 Dennis VC, Britton ML, Sirmans SM, Letassy NA, Freeman DA. The Clinical and Economic Implications of Alternate Day Lovastatin Therapy: A Retrospective Review of Use in Hypercholesterolemic Males. Conducted at the Oklahoma City Department of Veterans Affairs Medical Center, January 1994-March 1995 Landry JP, Britton ML, Letassy NA, Freeman DA. Impact of Clinical Pharmacists on the Composition and Cost of Antihypertensive Regimens Prescribed by Physician Assistants, conducted at the Oklahoma City Department of Veterans Affairs Medical Center, submitted for funding to SoloPak Pharmaceuticals Inc. for $1500, July 1994-April 1995 Beck JK, Britton ML, Letassy NA. An Evaluation of the Use of Bile Acid Sequestrants by Pharmacists in a Lipid Clinic. Conducted at the Oklahoma City Department of Veterans Medical Center, July 1993-March 1994 Howard CD, Letassy NL, Britton ML. An Evaluation of the Use of Niacin by Pharmacists in a Lipid Clinic. Conducted at the Oklahoma City Department of Veterans Affairs Medical Center, July 1993-March 1994 Pharm.D. Student Project Supervision and Collaboration Campbell M, Letassy NA, Britton ML. Evaluation of the Outcomes Resulting from a Competency-based Lipid Training Program for Pharmacists. Conducted with data collected by the University of Oklahoma College of Pharmacy Office of Continuing Education, May 1997-May 1998 Sachdev G, Britton ML. An Assessment of the Follow-up Care Provided to Patients Discharged from a Specialized Lipid Management Program. Conducted at the

Page 18: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 18

Oklahoma City Department of Veterans Affairs Medical Center, January 1995-April 1996 Carter JR, Britton ML, Letassy NA, Freeman DA. An Evaluation of the Use of Gemfibrozil before and after the Implementation of a Specialized Lipid Clinic. Conducted at the Oklahoma City Department of Veterans Affairs Medical Center, January 1992-April 1993 Crawley CL, Britton ML, Letassy NA, Freeman DA. Practitioner Response to High Blood Cholesterol Levels at a Department of Veterans Affairs Medical Center. Conducted at the Oklahoma City Department of Veterans Affairs Medical Center, January 1991-April 1992 (Dr. Crawley received the Upjohn Research Award for the outstanding research project in her Pharm.D. class.) Participated in Subject Recruitment and Data Collection for the Following Protocols as a Pharm.D. Resident Evaluation of an Investigational Antihistamine (825C) and Pseudoephedrine in the Treatment of Seasonal Allergic Rhinitis Symptoms, Burroughs Wellcome Company, Elaine Waller, Pharm.D., Principal Investigator, University of Texas at Austin College of Pharmacy, 1984 Single Dose Kinetics of Furosemide in Normal Young and Elderly Subjects, Hoechst-Roussel Pharmaceuticals, Elaine Waller, Pharm.D., Principal Investigator, University of Texas at Austin College of Pharmacy, 1983

PRESENTATIONS

Platform Presentations Britton ML. How to Set Up Clinical Services to Conduct Research. Sixth International Xiangya Clinical Pharmacy Forum. Changsha, Hunan, China, September 2016. Smith W, Britton ML, Hagemann T. Challenging Superstars and Managing “Problem Children” Residents. American Society of Health-System Pharmacists National Pharmacy Preceptors Conference, Washington, DC, August 2014. Smith W, Britton ML, Randall D. Managing Multiple Residencies in an Academic Setting. American Society of Health-System Pharmacists National Pharmacy Preceptors Conference, Washington, DC, August 2013. Britton ML. Engagement of Faculty in the Assessment Plan: Ubuntu and the Sankofa Bird. The Culture of Assessment: Best Practices, for the Assessment SIG. American Association of Colleges of Pharmacy Annual Meeting, San Antonio, Texas, July 2011. Letassy NA, Medina MS, Stroup J, Fugate S, Britton ML. Implementing Team-Based Learning Strategies in the Pharmacy Curriculum: A Remedy for What Ails Us. American Association of Colleges of Pharmacy Annual Meeting, Orlando, Florida, July 2007

Page 19: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 19

Britton ML, Er N, Hornbrook R, Letassy N, Medina M. A Database-Driven Approach to Streamline the Curricular Mapping Process. American Association of Colleges of Pharmacy Annual Meeting, San Diego, California, July 2006 Britton ML, Zierler-Brown SL, Drennen JK, Leader WG, Schwartz RN, Williams RO. Passion for the Basic Sciences in Pharmacy Professional Education: Are we Losing It and What Does It Mean for the Academy? American Association of Colleges of Pharmacy Annual Meeting, Cincinnati, Ohio, July 2005 Letassy N, Britton ML, Armor BA. Creating and Implementing a Diabetes Management Clinic. Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacy Midyear Clinical Meeting, Las Vegas, Nevada, December 2000 Alford KM, Anderson B, Britton ML, Letassy NA, Beck JK, Sirmans SM, Lawler F. Establishment of a Diabetes Management Service in a Family Medicine Center. Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacy Midyear Clinical Meeting, Las Vegas, Nevada, December 1998 Poster Presentations Dennis VC, Britton ML, Letassy NA, Fisher MJ, Bratzler DW, Sparks RA, Thompson BM. An Interprofessional Education Initiative at an Academic Health Center: Empowering Patients through Interprofessional Collaboration (EPIC). American Association of Colleges of Pharmacy Annual Meeting, Anaheim, July 2016. Farley J, Dennis VC, Britton ML, Goddard M, Carmichael LR. IMPACTing Access and Outcomes of Underserved Patients with Diabetes through Clinical Pharmacy Services Integration at a Federally Qualified Health Center. National Association of Community Health Centers Annual Meeting, San Diego, California, August 2014. Dennis VC, Farley J, Britton ML, Goddard M, Carmichael L. Improving Access and IMPACTing Outcomes of Underserved Patients with Diabetes through Clinical Pharmacy Services Integration at a Federally Qualified Health Center. Sixth Disparities Partnership Forum for the American Diabetes Association, Arlington, Virginia, October 2013. Letassy NA, Medina MS, Britton ML, Draugalis JR. A Progressive, Collaborative Process to Improve a Curriculum and Define an Assessment Program. American Association of Colleges of Pharmacy Annual Meeting, Chicago, July 2013. Dennis VC, Britton ML, Carter SM, Wheeler RE. Improved Examination Performance after Sequential Introductory and Advanced Pharmacy Practice Experiences at the Same Institutional Site. American Association of Colleges of Pharmacy annual Meeting, Chicago, July 2013. Farley J, Dennis VC, Britton ML, Goddard M, Carmichael L. Clinical Pharmacy Services Integration into a Federally Qualified Health Center: IMPACTing Outcomes in Underserved Patients with Diabetes. American Pharmacists Association Annual Meeting, Los Angeles, March 2013.

Page 20: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 20

Brahm N, Conway SE, Galbraith W, Honey BL, Johnson PN, Spies AR, Wilson JE, Britton ML. Focused Elective Tracks in a Professional Curriculum. American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, Florida, July 2012. Medina MS, Williams VN, Fentem L, Britton ML, Burton ME, Standifer K, Draugalis JR. Interprofessional Faculty Development Program Targeted at Early Career Faculty. American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, Florida, July 2012. Honey BL, Johnson PN, Condren M, Miller JL, Hagemann TM, Lewis TV, Brahm NC, Britton ML, Conway S, Wilson JE. Description of a Pediatric Pharmacotherapy Track for Doctor of Pharmacy Students. Pediatric Pharmacy Advocacy Group, Houston, Texas, April 2012. Dennis VC, Britton ML, Wheeler R. Effects of Scheduling Institutional Practice Experiences in the Same Facility on Performance and Perceptions of Learning. American Association of Colleges of Pharmacy Annual Meeting, San Antonio, Texas, July 2011. Medina MS, Britton ML, Letassy NA, Dennis VC, Stratton M, Lloyd A, McShan M, Harrison D, Kirkpatrick A, Ray NE, Wideman S, Webb R, Draugalis JR. Incremental Development of an Integrated Assessment Method for the Professional Curriculum. School Poster for the American Association of Colleges of Pharmacy Annual Meeting, San Antonio, Texas, July 2011. Conway SE, Medina MS, Letassy NA, Williams AS, Hughes CL, Britton ML. Assessment of Curriculum “Streams” of Knowledge and Skill Development. School Poster for the American Association of Colleges of Pharmacy Annual Meeting, Seattle, Washington, July 2010. Wilson JE, Britton ML, Lambert T. Student Assessment of a Distance Learning Environment. American Association of Colleges of Pharmacy Annual Meeting, Seattle, Washington, July 2010. Nguyen T, Britton ML, Harrison DR, Letassy NA, Armor BA, Tonemah D. Assessing the Need for Diabetes Self Management Education in the Vietnamese Community of the Oklahoma City Metropolitan Area: A Pilot Study. University of Oklahoma Health Sciences Center Diabetes Research Retreat, Oklahoma City, October 2009 Dennis VC, Ray NE, Wideman SD, Kirkpatrick AE, Britton ML. Evolution of an Introductory Pharmacy Practice Experience (IPPE) Course Sequence. School Poster for the American Association of Colleges of Pharmacy Annual Meeting, Boston, Massachusetts, July 2009 Wideman SD, Ray NE, Britton ML, Dennis VC. Experience with Student Reflective Essays Regarding Introductory Pharmacy Practice Experiences (IPPEs) During the First Professional Year. School Poster for the American Association of Colleges of Pharmacy Annual Meeting, Boston, Massachusetts, July 2009

Page 21: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 21

Letassy NA, Medina MS, Stroup J, Fugate S, Britton ML. The Impact of Team-Based Learning (TBL) on Student and Course Outcomes Compared to Lecture-Based Teaching Methods. American Association of Colleges of Pharmacy Annual Meeting, Orlando, Florida, July 2007 Letassy NA, Medina MS, Stroup J, Fugate S, Britton ML. The Impact of Team-Based Learning (TBL) on Student and Course Outcomes Compared to Lecture-Based Teaching Methods. Educational Scholarship Poster Day, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, February 2007 Bird J, Britton ML, Marcy TR, Barud S, Harrison DR, Armor BA, Scheid D, Lawler F. Evaluation of the process of care for diabetic patients with chronic kidney disease in a primary care setting. Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists, Anaheim, California, December 2006 Miller J, Stevens D, Britton M, Harrison D. Evaluation of the Quality of Care of Patients with Depression in a Family Medicine Primary Care Practice. Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists, Anaheim, California, December 2006 Er NL, Britton ML, Letassy NA, Medina M. The Use of a Management Information System in a Professional Pharmacy Program Evaluation. American Evaluation Association Annual Conference, Portland, Oregon, November 2006 Er N, Britton ML, Letassy NA, Medina MS. An On-line Academic Management System Supporting Curricular Evaluation. Annual Meeting of the American Association of Colleges of Pharmacy. Cincinnati, Ohio, July 2005 Letassy NA, Fugate SE, Stroup J, Medina MS, Britton ML. Using Team-Based Learning as an Instructional Strategy for Teaching an Endocrine Module for Third Year Pharmacy Students Across Two Campuses. Annual Meeting of the American Association of Colleges of Pharmacy. Cincinnati, Ohio, July 2005 Britton ML, Swanson KA, Medina MS. Use of a Weekly Open Forum to Acclimate Students in a Distance Education Environment. Annual Meeting of the American Association of Colleges of Pharmacy. Minneapolis, Minnesota, July 2003 Swanson KA, Britton ML, Medina MS. Pharmacy Student Progression in a Distance Education Environment. Annual Meeting of the American Association of Colleges of Pharmacy. Minneapolis, Minnesota, July 2003 Halloran MA, Britton ML, Buswell RC, Feuge R, Lockie SR. Clinical Privileging for Pharmacists in the United States Air Force. Annual Meeting of the American College of Clinical Pharmacy. Los Angeles, California, November 2000 Havrda DE, Letassy NA, Lavasanifar H, Britton ML. Report of Patient and Physician Satisfaction with a Pharmacist-Managed Anticoagulation Clinic in a Family Medicine Center. Annual Meeting of the American College of Clinical Pharmacy. Los Angeles, California, November 2000

Page 22: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 22

Britton ML, Letassy NA, Sirmans SM, Neal AVA, Freeman DA. An Interdisciplinary Clinic to Improve the Quality and Cost of Lipid Therapy. International Congress of Dietitians, Manila, Philippines, February 1996 Britton ML, Letassy NA, Sirmans SM, Neal AVA, Freeman DA. A Pharmacist Managed Lipid Clinic. Annual Meeting of the American Association of Colleges of Pharmacy, Philadelphia, Pennsylvania, July 1995 Britton ML, Letassy NA, Neal AVA, Freeman DA. An Interdisciplinary Lipid Clinic to Improve the Cost and Quality of Patient Care. Department of Veterans Affairs Medical Center Pharmacy Chief's Conference, Kansas City, Missouri, September 1993 Britton ML, Crawley CL, Letassy NA, Freeman DA, Lurvey PL. Practitioner Response at a Department of Veterans Affairs Medical Center to High Blood Cholesterol Levels. Annual Midyear Clinical Meeting of the American Society of Hospital Pharmacists, Orlando, Florida, December 1992 Britton ML, Lurvey PL, Bobinet DD. Impact of Prospective Medication Profile Review in Reducing Cost and Number of Prescriptions in a VA General Medicine Clinic. Annual Midyear Clinical Meeting of the American Society of Hospital Pharmacists, Atlanta, Georgia, December 1989 Washer KA, Lurvey PL, Jacobs EW, Britton ML. Consumer Demand for and Pharmacist Delivery of Prescription Information. American Association of Colleges of Pharmacy Annual Meeting, Portland, Oregon, July 1989 Lurvey PL, Washer KA, Jacobs EW, Britton ML. Consumer Perceptions of Useful Prescription Information. National Council on Patient Information and Education 7th Annual Conference on Prescription Drug Information and Education, Washington, DC, May 1989 Britton ML, Waller ES. Central Nervous System Toxicity Associated with Concurrent Use of Triazolam and Cimetidine. Annual Meeting of the Texas Society of Hospital Pharmacists, San Antonio, Texas, April 1984 Invited Presentations “Diabetes Overview,” Biweekly Conference, Center for Social Work in Healthcare, Zarrow School of Social Work at the University of Oklahoma Health Sciences Center, August 2018 “Review of Interprofessional Education Collaborative (IPEC) Competencies and Accreditation Requirements for Professional Programs,” All Professions Day Faculty Development Session, Oklahoma City, Oklahoma, September 2015 “Integrated Care and the Value of Interprofessional Education,” with Peggy Wisdom, MD, Teresa Fritz, LCSW, and Amie Torres, PA-C, 21st Annual Zarrow Mental Health Symposium (Integrating Healthcare: Mind, Body, and Spirit), Tulsa, Oklahoma, September 2015

Page 23: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 23

“Professionalism Evidenced by Fruits of the Spirit,” Graduation Banquet, Concordia University Wisconsin School of Pharmacy, Mequon, Wisconsin, May 2015 “Interprofessional Education on the OUHSC Campus,” panel participant, Public Health Grand Rounds, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, April 2015 “Panel Discussion: The Changing Face of Healthcare and the Critical Need for Social Work,” panel participant, Social Work in Health Care Conference, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, March 2015 “Entry into a Profession: Moving from Selfishness to Selflessness,” White Coat Ceremony, Concordia University Wisconsin School of Pharmacy, Mequon, Wisconsin, September 2011 “Curriculum Revitalization: Can We Have a Sustainable and Dynamic Process and Still Be Friends?” University of Florida College of Pharmacy Faculty Retreat, Gainesville, Florida, June 2009 “Curriculum Revitalization: Can We Have a Sustainable and Dynamic Process and Still Be Friends?” University of New Mexico College of Pharmacy Fall Retreat, Albuquerque, New Mexico, October 2007 “Curriculum Mapping: Can We Have a Sustainable and Dynamic Process and Still Be Friends?” American Association of College of Pharmacy Institute, Salt Lake City, Utah, June 2007 (with Nancy Letassy, Pharm.D.) "Reflections on the AACP Academic Leadership Fellows Program," American Association of Colleges of Pharmacy Interim Meeting, Washington, DC, February 2005 "Collaborative Care of Diabetes in Group Physician Practices," Endocrinology Grand Rounds, Department of Medicine, University of Oklahoma College of Medicine, November 2004 “University of Oklahoma College of Pharmacy Distance Education Program,” University of Tennessee College of Pharmacy, Memphis, Tennessee, December 2003 (presented via distance education technologies) "Leadership and Academic Achievement," Rho Chi Banquet, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, March 2002 “Drug Therapy for Glycemic Control in Type 2 Diabetes,” 4th Annual Primary Care Update, sponsored by the Department of Family Medicine, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, May 2001 “Therapy of Diabetic Dyslipidemias,” for Family Medicine Physicians and Residents, Department of Family and Preventive Medicine, Family Medicine Center, University of Oklahoma Health Sciences Center, April 2001

Page 24: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 24

“Evidence-based Management of Diabetic Dyslipidemia,”, sponsored by Merck and Co. for University of Oklahoma College of Pharmacy students and faculty, September 2000. “Pharmacologic Issues in the Elderly,” Grand Rounds, Department of Family and Preventive Medicine, Family Medicine Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, July 1998 “Update on Lipid Management,” for physicians and physicians associates, sponsored by Merck Human Health, Oklahoma City, Oklahoma, June 1998 “Pharmacist-Directed Lipid Clinics,” Texoma Region (Texas/Oklahoma Department of Defense Medical Treatment Facilities) Medication Protocol Conference, sponsored by the 72nd Medical Group, Tinker Air Force Base, Oklahoma City, Oklahoma, May 1998 “Pharmaceutical Care,” presentation for staff physicians, physicians associates, and nurse practitioners, 72nd Medical Group, Tinker Air Force Base, Oklahoma City, Oklahoma, April 1998 “A Protocol for Pharmacist Management of Lipid Disorders,” College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, October 1997 “Practical Considerations in the Management of Dyslipidemias,” for physicians and physician assistants at Tinker Air Force Base Hospital and Clinics, Oklahoma City, Oklahoma, September 1997 “Lipid-Modifying Drugs,” for sales representatives of the Parke-Davis Company at the University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, December 1996 “Pharmacotherapy of Asthma” for primary care providers of the Heartland Health Plan of Oklahoma, Lawton, Oklahoma, December 1996 “Current Management of Lipid Disorders,” Medical Staff Grand Rounds, Department of Veterans Affairs Medical Center, Big Spring, Texas, November 1996 “Pharmacotherapy of Asthma,” for primary care providers of the Heartland Health Plan of Oklahoma, Oklahoma City, Oklahoma, September 1996 “Current Management of Dyslipidemia” lecture and small group case discussion sessions for pharmacists and physicians employed by Pru-Care and Integrated Pharmacy Solutions, Inc., Oklahoma City, Oklahoma, September 1996 “Current Trends in Lipid Management,” for sales representatives of Merck Human Health, Oklahoma City, Oklahoma, May 1996 “Evaluation and Management of Dyslipidemia,” Grand Rounds, Department of Family Medicine, Family Medicine Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, March 1996

Page 25: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 25

“The Medication Use Process,” Intern and Resident Conference, Department of Family Medicine, Family Medicine Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, February 1996 “Management of Dyslipidemia,” Medical Staff, Ft. Sill Army Hospital, Lawton, Oklahoma, February 1996 “Enhancing Patient Compliance,” Medical Staff, Jane Phillips Memorial Hospital, Bartlesville, Oklahoma, February 1996 "Non-traditional Roles for Pharmacists in Ambulatory Care Settings," Grand Rounds, Department of Family Medicine, Family Medicine Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, December, 1995 "Alumni Reunion Program," for 1995 alumni of the Lipid Training Program for Pharmacists, 30th Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists, Las Vegas, Nevada, December 1995 "Management of Dyslipidemia," Medical Staff of the Talihina Indian Hospital, Poteau, Oklahoma, November 1995 "Advanced Pharmaceutical Services: Experiences at the Oklahoma City Department of Veterans Affairs Medical Center," Pharmacy Service of the Fort Sill Army Medical Center, Oklahoma City, Oklahoma, September 1995 "Advanced Pharmaceutical Services: Experiences at the Oklahoma City Department of Veterans Affairs Medical Center," College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, June 1995 "The Development and Organization of a Pharmacist-run Lipid Clinic," National Pharmacy Cholesterol Council, Miami, Florida, December 1994 "Therapy of Dyslipidemia: A Focus on Pharmaceutical Care," Owen Healthcare, Houston, Texas, March 1994 "Implementation and Cost Justification of a Multidisciplinary Lipid Clinic," Diversified Pharmaceutical Services, United HealthCare Corporation, Minneapolis, Minnesota, January 1994 "Case Discussions: Dyslipidemia," Joint Meeting of the Oklahoma and Texas Regional Cholesterol Councils, San Antonio, Texas, September 1992 "Drug Therapy in the Post-Polio Patient," Oklahoma Easter Seal Society, Oklahoma City, Oklahoma, August 1992 "Managing the Patient with Hyperlipidemia," Physician Associate Program Board Preparation Course, Physician Associate Program, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, July 1992 "A Systematic Approach to Geriatric Medication Evaluation: A Case Study," Oklahoma Geriatric Education Center Monthly Interdisciplinary Conference,

Page 26: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 26

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, May 1991 "Therapy of Hypertension," Clinical Review of Pharmacotherapeutics for Physician Assistants , University of Oklahoma Tulsa Medical College, Tulsa, Oklahoma, April 1991 "Therapy of Hypertension," Clinical Review of Pharmacotherapeutics for Physician Assistants , University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, April 1991 "Impact of Medication Profile Review on Prescribing in a General Medicine Clinic," Samford University School of Pharmacy, Birmingham, Alabama, March 1991 "The Medical and Dental Implications of Systemic Disease: A Panel Presentation and Discussion," with Stewart Shapiro, D.M.D., Ph.D., James Mold, M.D., Richard Glass, D.D.S., Ph.D., and Midge Irwin, Ph.D. Annual Meeting of the Oklahoma Dental Association, Oklahoma City, Oklahoma, April 1990 "Pharmacist Managed Outpatient Clinics: Role in a Cardiovascular Risk Reduction Unit," Pharmacy Directors' Monthly Meeting, Oklahoma City, Oklahoma, April 1990 "Psychotropic Drug Use," Social Work Student Seminar, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, March 1990 "Polypharmacy: A Case Study," with Peter Winn, M.D., and Larry Cohen, Pharm.D., Oklahoma Geriatric Education Center Monthly Interdisciplinary Conference, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, December 1989 "Survey of Medication Use in the Outpatient Clinics of the Oklahoma City Department of Veterans Affairs Medical Center," Clinical Executive Board of the Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, October 1987 "Current Status of Therapy for Osteoporosis," Texas Department of Mental Health and Mental Retardation Physician's Conference, Austin, Texas, October 1985 "Comparison of First and Second Generation Sulfonylureas," Pharmacy and Therapeutics Committee, Prucare of Austin, Texas, March 1985 "Selection of Oral Erythromycin Products," Pharmacy and Therapeutics Committee, Prucare of Austin, Texas, June 1984 "Arthritis Medications," Arthritis Patient Group, South Austin Clinic, Austin, Texas, February 1984 "Pyridium-Induced Hemolytic Anemia," Pharmacist In-Service, Department of Veterans Affairs Medical Center, Kansas City, Missouri, January 1983

Page 27: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 27

Continuing Education for Pharmacists or Other Health Professionals “Meet the Professor,” Presentation for Graduate Students and Faculty, Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, March 2012 “New Drug Update,” Annual Continuing Medical Education Conference for Physician Assistants, Norman, Oklahoma, October 2009 “How Do I Look? PGY2 Residency Programs,” with David Warner, Pharm.D., American Society of Health-System Pharmacists National Residency Preceptor’s Conference, Washington, D.C., August 2008 “Diabetes Case Management: What Would You Do?” Annual Indian Health Service Seminar, Tulsa, Oklahoma, February 2007 “New Drug Update,” Annual Continuing Medical Education Conference for Physician Assistants, Oklahoma City, Oklahoma, September 2006 "Targets and Techniques in Treating Type 2 Diabetes," LEAD program sponsored by Aventis for physician assistants and nurse practitioners, Oklahoma City, Oklahoma, June 2002 "Patient Compliance," Cardiovascular Diseases Learning Community, American Society of Health-Systems Pharmacists, Baltimore, Maryland, June 2002 "Patient Interviewing," Cardiovascular Diseases Learning Community, American Society of Health-Systems Pharmacists, Baltimore, Maryland, June 2002 "Targets and Techniques in Treating Type 2 Diabetes," LEAD program sponsored by Aventis for pharmacists, physician assistants, and nurse practitioners, Fort Worth, Texas, January 2002 "Contemporary Issues in the Management of Type 2 Diabetes Mellitus," for pharmacists, Federal Pharmacy Conference, University of Texas at Austin College of Pharmacy, Austin, Texas, November 2001 “New Drug Update,” Annual Continuing Medical Education Conference for Physician Assistants, Oklahoma City, Oklahoma, October 2001 "Administrative and Reimbursement Issues," Anticoagulation Traineeship for Health Care Professionals, University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma, May 2001 “A Protocol for Managing Lipid Disorders” and “Issues Involved in the Establishment and Justification of a Pharmacist-managed Lipid Clinic,” University of Oklahoma Lipid Training Program, Oklahoma City, Oklahoma, March 2001; July and October 2000; March and October 1999; January and February 1998; April, May, June, September, and November 1997; March, April, June, October, and November 1996; March, June, October, and November 1995; and November 1994

Page 28: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 28

“Department of Defense Treatment Guidelines for Treatment of Hyperlipidemia,” Pharmacoeconomics Conference, sponsored by the University of Texas College of Pharmacy, San Antonio, Texas, January 2000 “Approaches for Managing Lipid Therapy Cost in Outpatient Treatment Facilities,” Pharmacoeconomics Conference, sponsored by the University of Texas College of Pharmacy, San Antonio, Texas, January 2000 “New Drug Update,” Annual Continuing Medical Education Conference for Physician Assistants, Tulsa, Oklahoma, September 1999 “Reimbursement Strategies for Primary Care Clinics,” University of Oklahoma Fall Continuing Education Conference, Oklahoma City, Oklahoma, November 1998 “Clinical Practice Forum: Disease Management in Contemporary Practice,” moderator and member of panel discussion, University of Oklahoma Fall Continuing Education Conference, Oklahoma City, Oklahoma, November 1998 “Primary Care Through Patient Focused Practice,” moderator and member of panel discussion, University of Oklahoma Fall Continuing Education Conference, Oklahoma City, Oklahoma, November 1998 “Management of Hyperlipidemia in Diabetic Patients,” Federal Pharmacy Conference sponsored by the Continuing Education Division of the University of Texas at Austin, Austin, Texas, November 1998 “Managing a Type II Diabetic: A Worshop,” Federal Pharmacy Conference sponsored by the Continuing Education Division of the University of Texas at Austin, Austin, Texas, November 1998 “Managing Hyperlipidemia in a Type II Diabetic: A Workshop,” Federal Pharmacy Conference sponsored by the Continuing Education Division of the University of Texas at Austin, Austin, Texas, November 1998 “Current Pharmacologic Agents Used in the Treatment of Hyperlipidemia and Enhancing Patient Compliance Toward Treatment,” Veterans Affairs Pharmacotherapy Conference sponsored by the Continuing Education Division of the University of Texas at Austin, Austin, Texas, October 1998 “Workshop: A Patient with Elevated Triglycerides and Low HDL-Cholesterol,” Veterans Affairs Pharmacotherapy Conference sponsored by the Continuing Education Division of the University of Texas at Austin, Austin, Texas, October 1998 “Developing a Service Within a Primary Care Setting,” Veterans Affairs Pharmacotherapy Conference sponsored by the Continuing Education Division of the University of Texas at Austin, Austin, Texas, October 1998 “Roles of Pharmacists in Lipid Management,” Pharmacy in the 21st Century: Service, Commitment and Caring, a program offered at the 32nd Annual Arkansas Association of Health-System Pharmacists Fall Seminar, Little Rock, Arkansas, October 1998

Page 29: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 29

“New Drug Update,” Annual Continuing Medical Education Conference for Physician Assistants, Oklahoma City, Oklahoma, September 1998 “Current Trends in Lipid Management,” Annual Continuing Medical Education Conference for Physician Assistants, Oklahoma City, Oklahoma, September 1998 “Management of Diabetic Dyslipidemia: A Case Study,” Annual Meeting of the American Society of Health-System Pharmacists, Baltimore, Maryland, June 1998 “Considerations in Establishing a Pharmacist-Managed Lipid Clinic,” Indiana Society of Health-System Pharmacists, Indianapolis, Indiana, October 1997 “Dyslipidemia: Patient Management in a Lipid Clinic,” for Focus ‘97, a program sponsored by the California Society of Health-System Pharmacists, Los Angeles, California, April 1997 “New Drug Update,” Annual Continuing Medical Education Conference for Physician Assistants, Oklahoma City, Oklahoma, October 1996 “First Annual VA Pharmacotherapy Conference: Management of Lipid Disorders,” for VA pharmacists sponsored by the University of Texas at Austin, San Antonio, Texas, July 1996 “Current Trends in the Management of Dyslipidemia,” for pharmacists of the Federal Bureau of Prisons, Pensacola, Florida, April 1996 “Considerations in Establishing Pharmacist Managed Clinics,” Third Pharmacoeconomics Conference for the Department of Defense, sponsored by the University of Texas College of Pharmacy at San Antonio, Texas, January 1996 "Managing the Costs of Lipid-Modifying Therapy: Experiences at the Oklahoma City Department of Veterans Affairs Medical Center," for pharmacists in the Department of Veterans Affairs, 30th Annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists, Las Vegas, Nevada, December 1995 "The Pharmacists’ Role in the Management of Patients with Dyslipidemia: A Focus on Pharmaceutical Care," Annual Meeting of the Louisiana Society of Hospital Pharmacists, New Orleans, Louisiana, March 1995 "Pharmaceutical Care for Patients with Hypercholesterolemia," Continuing Education Program for Pharmacists of Merck-Medco Managed Care, Fort Worth, Texas, December 1994 "Management of Hypertension in the Elderly," 16th Midyear Conference, American Society of Consultant Pharmacists, Boca Raton, Florida, May 1994 "Formulary Considerations for Lipid-Modifying Therapy," Tri-Services Pharmacoeconomic Center (PEC), Fort Sam Houston, San Antonio, Texas, January 1994 “A Protocol for Managing Lipid Disorders” and “Issues Involved in the Establishment and Justification of a Pharmacist-managed Lipid Clinic,” National Pharmacy

Page 30: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 30

Cholesterol Council Lipid Training Program, Oklahoma City, Oklahoma, June and October 1993 "Management of Dyslipidemia," Medical Staff Monthly Continuing Education Program, Department of Veterans Affairs Outpatient Clinic, Lawton, Oklahoma, July 1992 "Case Discussion: Dyslipidemia," as part of the Oklahoma Pharmacy Cholesterol Council Symposium on Treatment of Lipid Disorders, Annual Meeting of the Oklahoma Society of Hospital Pharmacists, Tulsa, Oklahoma, May 1992 "A Practical Approach to Treating Hyperlipidemias," University of Oklahoma Continuing Education Program for Pharmacists, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, November 1991 "A Practical Approach to Treating Hyperlipidemias," University of Oklahoma Continuing Education Program for Pharmacists, University of Oklahoma Health Sciences Center, Tulsa, Oklahoma, November 1991 "Treatment of Constipation," State Veterans Centers Physician Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, September 1989 "Food and Drug Interactions, Part 2," Dietetic Service Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, August 1989 "Food and Drug Interactions," State Veterans Centers Physician Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, June 1989 "Food and Drug Interactions, Part 1," Dietetic Service Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, June 1989 "Polypharmacy," State Veterans Centers Physician Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, February 1989 "Principles of Anticoagulation," Nursing Service Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, January 1989 "Use of Amantadine in the Treatment and Prophylaxis of Influenza A Viral Infections," State Veterans Centers Physician Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, October 1988 "Clinical Use of Sulfonylurea Drugs in the Management of Type II Diabetes Mellitus," State Veterans Centers Physician Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, September 1988

Page 31: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 31

"Update on Histamine H2-Antagonist Therapy," State Veterans Centers Physician Continuing Education, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, July 1988 "New Prescription Drugs of 1985," "OTC Ophthalmic Preparations," 33rd Annual Postgraduate Pharmacy Seminar, University of Texas, Austin, Texas, September 1985 "The Role of Verapamil in the Therapy of Essential Hypertension," Continuing Pharmacist Education sponsored by Knoll Pharmaceuticals, Austin, Texas, August 1985 "Therapy of Diabetes Mellitus," "New Drug Products of 1984-85," and "OTC Ophthalmics"; Continuing Education for Revco Pharmacists, Dallas, Texas, January 1985; San Marcos, Texas, March 1985; El Paso, Texas, April 1985 "Role of Calcium Supplementation in Post-menopausal Osteoporosis," Staff Continuing Education, South Austin Clinic, Austin, Texas, August 1983 "Guanabenz and Captopril: Two New Antihypertensives," Staff Continuing Education, South Austin Clinic, Austin, Texas, May 1983 Inservice Presentations “How to Better Manage Your Asthma,” for patients and providers of the Heartland® Health Plan of Oklahoma, Oklahoma City, Oklahoma, October 1997 “Pain Management with Non-narcotic Analgesics,” for dentists and dental technicians of the Dental Service, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, October 1996 “Asthma Medications,” for patients of the Heartland Health Plan of Oklahoma, Family Medicine Center, University of Oklahoma Health Sciences Center, August 1996 “Role of Metformin in Type II Diabetes,” for Residents in the Family Medicine Post-graduate Medical Education Program, Family Medicine Center, University of Oklahoma Health Sciences Center, May 1996 “Lipid-Modifying Drugs: Case Studies,” for Interns and Residents in the Family Medicine Post-graduate Medical Education Program, Family Medicine Center, University of Oklahoma Health Sciences Center, May 1996 “The Medication Use Process,” for Interns in the Family Medicine Post-graduate Medical Education Program, Family Medicine Center, University of Oklahoma Health Sciences Center, February 1996 "Monitoring of Antihypertensive Medications," Nursing Staff Education Program, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, November 1994

Page 32: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 32

"Management of Chronic Pain," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, February 1991 "Hyperlipidemias in Elderly Patients: To Treat or Not to Treat," Geriatric and Rehabilitation Conference, O'Donoghue Rehabilitation Institute, Oklahoma City, Oklahoma, January 1991 "Management of Constipation in the Elderly," Geriatric and Rehabilitation Conference, O'Donoghue Rehabilitation Institute, Oklahoma City, Oklahoma, November 1990 "Risk of Cerebral Hypoperfusion with Antihypertensive Therapy," Geriatric and Rehabilitation Conference, O'Donoghue Rehabilitation Institute, Oklahoma City, Oklahoma, November 1990 "Antihypertensive Effects on Cerebral Blood Flow," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, January 1990 "The Drug Use Evaluation Process," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, August 1989 "Food and Drug Interactions," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, July 1989 "Use of Digibind," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, May 1989 "Common Topical Dermatological Preparations," with Patricia Wright, Pharm.D., Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, April 1989 "Impact of Prospective Medication Profile Review on Cost and Number of Prescriptions in the General Medicine Clinic," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, March 1989 "Common Side Effects of Anticonvulsant Therapy," Physical Therapists Staff Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, January 1989 "Use of Amantadine in the Treatment and Prophylaxis of Influenza A Viral Infections," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, October 1988 "Safety Issues with the Use of Antihypertensive Drug Therapy," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, September 1988

Page 33: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 33

"Update on Histamine H2-Antagonist Therapy," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, July 1988 "The Educational Background and Role of the Doctor of Pharmacy," Ambulatory Care Service Weekly Conference, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, June 1988 "Clinical Use of Corticosteroids," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, August 1986 "Drug Therapy of Lupus Nephritis," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, March 1986 "Current Status of Therapy for Post-menopausal Osteoporosis," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, February 1986 "Potassium Supplementation: Indications and Products," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, November 1985 "The Role of Calcium Channel Blockers in the Therapy of Hypertension," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, October 1985 "Review of Calcium Channel Blockers," Internal Medicine Staff Conference, Brackenridge Hospital Clinics, May 1985 "Therapy of Essential Hypertension," Internal Medicine Staff Conference, Brackenridge Hospital Clinics, May 1985 "Treatment of Status Epilepticus," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, May 1984 "Therapy of Gout," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, February 1984 "Calcium Channel Antagonists," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, November 1983 "Triazolam," Internal Medicine Staff Conference, Brackenridge Hospital, Austin, Texas, February 1983

COMMITTEE APPOINTMENTS

Academic

Oklahoma City University

Member, Strategic Planning Committee, November 2017 to present Oklahoma City University Physician Assistant Program

Chair, Didactic Committee, October 2016 to present

Page 34: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 34

Member, Academic Advancement Committee, October 2016 to present Member, Operations Committee, October 2016 to present Member, Admissions Committee, October 2016 to present

University of Oklahoma College of Pharmacy

Member, Ad Hoc Committee to Review Strategic Plan, August 2013-May 2014 Member, Community Pharmacy Clinical Services Development Committee, July 2012-August 2013 Chair, Self-Study Committee in preparation for college accreditation in September 2011, September 2010-September 2011 Chair, Community Pharmacy Clinical Services Development Committee, September 2010-June 2011 Chairman, Search Committee for Associate Dean for Academic Affairs-Tulsa, January 2005-March 2005 Member, Residency Review Committee, June 2006-September 2016 Interim Chair, Residency Review Committee, December 2006-August 2008, May 2004-May 2005 Member, Academic Standings Committee, September 2000-present Member, Curriculum Committee, September 2000-present Member, Planning Committee, September 1999-July 2003 Chairman, Mosier Selection Committee, January-March 2001 Member, Mosier Selection Committee, January-March 2000 Chairman, Search Committees for Ambulatory Care Faculty Positions, January 1999-April 2000, January-March 1998, January-March 1997, April 1995-April 1996 Member, Professional Practice Plan Committee, June 1998-June 2001 Member, Promotions and Tenure Guidelines Committee, June 1998-December 1998 Member, Self-Study Committee, preparatory to the ACPE accreditation visit, May 1998-March 2000 Member, Lectures Committee, May 1998-August 2000

Page 35: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 35

Member, Working Group to Develop Alternative Pathway to the Pharm.D. Degree (with members from the Southwestern Oklahoma State University School of Pharmacy), October 1997-August 1999 Chairman, Educational Policy, Planning, and Implementation Committee, October 1997-September 2000 Member, Search Committee for Pharmacy Practice Department Chair, October 1997-April 1998 Member, Ad Hoc Committee on the Use of Alcohol at College Functions, November 1995- February 1996 Chairman, Curriculum Committee, October 1995-September 1997 Member, Search Committee for Education Specialist, February 1995-May 1995 Member, Strategic Planning Committee, Pharmacy Practice Section, September 1994-September 1996 Member, Curriculum Committee, January 1994-September 1995 Member, Doctor of Pharmacy Committee, January 1987-May 1987 and January 1990-June 2001 Member, Subcommittee for Physical and Clinical Resources (in preparation for ACPE accreditation visit), November 1990-August 1991 Member, Committee to Evaluate Practicum Courses PHAR 5015, 5025, 5033, 5043, February 1990 Member, Admissions Committee, January 1989-November 1990

University of Oklahoma Health Sciences Center

Member, Higher Learning Commission (HLC) Accreditation Committee for the University of Oklahoma System, September 2015-September 2016 Member, OUHSC Academic Affairs Policy Coordination Committee, September 2015-September 2016 Chair, Policy Review Working Group of the Physician Association Education Committee, February 2015-February 2016 Member, Physician Associate Education Committee, January 2015-February 2016 Member, Faculty Development Subcommittee of the HSCIEPC, January 2015-September 2016

Page 36: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 36

Core Faculty Member, Health Sciences Center Interprofessional Education and Practice Collaborative (HSCIEPC), August 2012-September 2016 Member, Faculty-At-Large, Presidential Professorship Committee, August 2011-July 2013 Member, North Central Association of the Higher Learning Commission Accreditation Criterion Three Committee, October 2010-May 2011 Member, Pharmacy Dean Search Committee, May-November 2006 Faculty Appeals Board, August 2004-June 2008 Funded Member for Protocol Design and Assessment, Oklahoma Center for Family Medicine Research, July 1998-September 1999 Member, Academic Affairs and Promotions Committee, Physician Associate Program, Department of Family Medicine, College of Medicine, University of Oklahoma Health Sciences Center, March 1995-January 1999 Member, Masters Committee for Ray Beddoe, Pharm.D., D.M.D., Master's candidate in Periodontics, November 1990-April 1991

University of Texas College of Pharmacy

Member, Committee for Content Development of the Pre-Clinical Component, PHR 366T Restructuring Project, College of Pharmacy, University of Texas at Austin, 1985 Member, Committee to Evaluate Assessments for the Experiential Component of the Doctor of Pharmacy Curriculum, College of Pharmacy, University of Texas at Austin, 1983

Healthcare Institutions or Agencies

Good Shepherd Clinic

Member, Alumni Board, August 2017 to present

Department of Family and Preventive Medicine, University of Oklahoma College of Medicine

Member, Physician Associate Program Admissions Committee, January 2013-March 2013

Member, Diabetes Advisory Group, Department of Family and Preventive Medicine, University of Oklahoma College of Medicine, August 1996-September 2016

Oklahoma Pharmacists Association

Member, Professional Affairs Committee, January 1998-August 1998

Page 37: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 37

Oklahoma State and Education Employees Group Insurance Board

Chairman, Drug Utilization Evaluation Committee, October 1997-October 2004

Oklahoma State Board of Nursing

Member (by appointment from the Oklahoma Pharmacists Association), Formulary Advisory Council, Oklahoma State Board of Nursing, August 1996-July 1999

Heartland® Health Plan of Oklahoma

Member, Diabetes Task Force, May 1997-June 1998 Member, Asthma Task Force, April 1996-June 1998 Member, Pharmacy and Therapeutics Committee, February 1996-December 2003

Oklahoma City Department of Veterans Affairs Medical Center

Member, Integrated Health Teams Ad Hoc Committee, October 1994-September 1995 Member, Ancillary Laboratory Testing Committee, September 1992-September 1995 Chairman, Search Committee for Infectious Disease Clinical Specialist, January 1990-November 1993 Member, Pharmacy Standards Board, December 1989-September 1995 Member, Adverse Drug Reaction Subcommittee, March 1989-September 1995 Member, Drug Use Evaluation Subcommittee, March 1989-September 1995 Chairman, Substance Abuse Committee, July 1990-December 1990 Chairman, Search Committee for Pharmacokinetics Clinical Specialist (with the University of Oklahoma College of Pharmacy), May 1990-October 1990 Chairman, Search Committee for Psychopharmacy Clinical Specialist (with the University of Oklahoma College of Pharmacy), March 1989-March 1990 Chairman, Search Committee for Ambulatory Care Clinical Specialists (with the University of Oklahoma College of Pharmacy), January 1989-September 1995 Member, Substance Abuse Committee, November 1988-March 1993

Page 38: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 38

Member, Pharmacy and Therapeutics Committee, September 1988-October 1993 Member, Ambulatory Care Committee, May 1988-May 1993 Member, Ambulatory Care Advisory Committee, Oklahoma, May 1988-May 1993

OTHER APPOINTMENTS AND ACTIVITIES

National Professional Service

Selected Member, Consensus Recommendations Panel, Ambulatory Care Conference and Summit, American Society of Health-System Pharmacists, Dallas, Texas, March 2014 Member, Payment Policy Workgroup, American Association of Colleges of Pharmacy, August 2012-July 2013 Selected Member, Consensus Recommendations Panel, Pharmacy Practice Model Initiative Summit, American Society of Health-System Pharmacists, Dallas, Texas, November 2010 Member, Commission on Credentialing, American Society of Health-System Pharmacists, March 2006-December 2009 Chairman, Standards Subcommittee, Commission on Credentialing, American Society of Health-System Pharmacists, March 2008-December 2009 Invited Expert Reviewer for the American Society of Health-System Pharmacists for the following residency programs:

PGY1 Pharmacy Residency, University of Minnesota College of Pharmacy, October 2009 PGY1 Pharmacy Residency, Western New York Veterans Health System, Buffalo, New York, October 2009 PGY1 Pharmacy Residency, Department of Veterans Affairs Medical Center, Roseburg, Oregon, July 2009 PGY2 Ambulatory Care Pharmacy Residency, Parkland Health System, Dallas, Texas, June 2009 PGY1 Residency Program Accreditation for Chalmers P. Wylie Veterans Clinic, Columbus, Ohio, April 2009 PGY1 Residency Program Accreditation for Saint Thomas Medical Center, Nashville, Tennessee, March 2009

Page 39: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 39

PGY1 Pharmacy Residency and PGY2 Ambulatory Care Pharmacy Residency, William Middleton Veterans Affairs Medical Center, Madison, Wisconsin, July 2008 PGY1 Pharmacy Residency and PGY2 Internal Medicine Pharmacy Residency, Jefferson Barracks and John Cochran Divisions of the St. Louis Veterans Health Care System, St. Louis, Missouri, May 2008 PGY1 Pharmacy Residency, Valley Hospital, Ridgewood, New Jersey, April 2008 PGY1 Pharmacy Residency, Southern Arizona Veterans Health Care System, Tucson, Arizona, March 2008 PGY1 Pharmacy Residency, St. Mary’s Medical Center, Huntington, West Virginia, November 2007 PGY2 Ambulatory Care Pharmacy Residency, Coastal Medical, Inc., Providence, Rhode Island, September 2007 PGY2 Ambulatory Care Pharmacy Residency, William Beaumont Hospital, Royal Oak, Michigan, May 2007 PGY1 Pharmacy Residency, Central Texas Veterans Health Care System, Temple, Texas, March 2007 PGY1 Pharmacy Residency Accreditation, Millcreek Community Hospital and LECOM School of Pharmacy, Erie, Pennsylvania, September 2006 PGY2 Ambulatory Care Pharmacy Residency, William Jennings Bryant Dorn VA Medical Center, Columbia, South Carolina, May 2006 PGY2 Ambulatory Care Pharmacy Residency, Columbus Regional Health System, Columbus, Georgia, April 2005 PGY2 Ambulatory Care Pharmacy Residency, University of Iowa Hospitals and Clinics, Iowa City, Iowa, May 2004 PGY2 Ambulatory Care Pharmacy Residency, University of Tennessee Medical Center, Knoxville, Tennessee, May 2002 Primary Care Pharmacy Residency, Whiteriver, Arizona, Indian Hospital, October 1995

Member, Site Visit Team for Accreditation of the Professional Program at the University of North Carolina School of Pharmacy, Chapel Hill, North Carolina, March 2006 Member, Nominations Committee, American Association of Colleges of Pharmacy, July 2005-June 2006

Page 40: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 40

Moderator and Member of the Design Team, Cardiovascular Diseases Learning Community for the 2002 Annual Meeting, American Society of Health-Systems Pharmacists, Baltimore, Maryland, November 2001-June 2002

Professional Practice and Leadership Development

Faculty Team Leader for OUHSC, IPEC Institute, Washington, DC, May 2013 Faculty Team Leader for OUHSC, IPEC Institute, Atlanta, October 2012 Mentor for Michael J. Smith, Ph.D., AACP Academic Leadership Fellows Program, August 2012-July 2013 Mentor for Vincent Dennis, Pharm.D, AACP Academic Leadership Fellows Program, August 2007-July 2008 Participant, Academic Leadership Fellows Program, American Association of Colleges of Pharmacy, August 2004-July 2005 Participant, American College of Clinical Pharmacy Leadership Experience, Kansas City, March 2004 Member, Advisory Board, Alcalde XVI Southwest Leadership Conference for Pharmacy Residents, Fellows, and Preceptors, July 2001-April 2002 Participant, American Association of Colleges of Pharmacy Educational Institute, Leesburg, Virginia, May 2000 Participant, American Association of Colleges of Pharmacy Educational Institute, Leesburg, Virginia, May 1999 Invited Facilitator, "Basic Clinical Skills Program", sponsored by the University of Tennessee College of Pharmacy for Columbia Healthcare Corporation and Owen Healthcare, Inc. with support from Novartis in Memphis, Tennessee, March 1997 Participant, American Association of Colleges of Pharmacy Educational Institute, Williamsburg, Virginia, May 1996 Invited Facilitator, "Developing Basic Skills and Knowledge Base to Provide Pharmaceutical Care in a Rapidly Changing Health Care Arena: A Program for VA Staff Pharmacists", sponsored by the University of Tennessee College of Pharmacy, Memphis Department of Veterans Affairs, and CibaGeneva Pharmaceuticals and conducted in Memphis, Tennessee on January 5-7, January 26-28, February 23-25, 1996 Member, Task Force on the Future of Pharmacy Practice in Oklahoma of the Oklahoma Pharmaceutical Association, appointed by the Dean, College of Pharmacy, University of Oklahoma Health Sciences Center, February 1995-July 1995

Page 41: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 41

Invited Participant, Pharmaceutical Care '94: A Statewide Oklahoma Pharmacy Conference on Pharmaceutical Care, November 1994 Invited Participant, Future Directions in VA Ambulatory Care, sponsored by the Association of American Medical Colleges and the Cleveland, Minneapolis, and Birmingham REMEC's, Tampa, Florida, September 1993 Invited Participant, Department of Veterans Affairs Pharmacy Service Chief's Conference on the Future of Pharmacy Practice, Kansas City, Missouri, September 1993 Member, Oklahoma Pharmacy Cholesterol Council, 1991-94 Founding Faculty Advisor, Phi Lambda Sigma Pharmacy Leadership Society, College of Pharmacy, University of Oklahoma Health Sciences Center, January 1990-May 1992 Key Faculty Member from the College of Pharmacy, Oklahoma Geriatrics Education Center, University of Oklahoma Health Sciences Center, September 1989-January 1991 Invited Participant, Department of Veterans Affairs Pharmacy Service Consensus Conference on the Future of Pharmacy Practice, Olive Branch, Mississippi, March 1989

Consultancies

Consultant, Diabetes Advisory Panel for Pfizer Pharmaceuticals, March 1998-December 1999 Consultant, to assist in the establishment of a pharmacy-based lipid management service at the McAllen VA Outpatient Clinic, McAllen, Texas, April 1998 Consultant, to evaluate and recommend changes for lipid management services in the Central Texas VA Health System, Waco, Texas, August 1997 Consultant, Federal Establishment Grant for Departments of Family Medicine to evaluate diabetic management services in the University of Oklahoma Family Medicine Center, Department of Family and Preventive Medicine, University of Oklahoma College of Medicine, August 1996-February 1999 Consultant to the Oklahoma State Department of Mental Health, Oklahoma City, Oklahoma, August-November 1988 Consultant to develop clinical pharmacy services, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, June-August 1987 Consultant to develop clinical pharmacy services, Department of Pharmacy Services, Austin-Travis County Health Department, City of Austin, Texas, 1985 Consultant for formulary decisions, Prucare of Austin, Texas, 1984-86

Page 42: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 42

Review of Professional Writing

Reviewer of the Prevention of the Type 2 Diabetes Evidence-Based Nutrition Practice Guideline for the Academy of Nutrition and Dietetics Evidence-Based Practice Committee, August 2014 Reviewer for the Evidence Analysis Library, Academy of Nutrition and Dietetics, October 2013

Invited Reviewer for Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation, Commission on Therapeutics, American Society of Health-System Pharmacists, July 2006 Invited Reviewer for Therapeutic Position Statement on Strict Glycemic Control in Patients with Diabetes, Commission on Therapeutics, American Society of Health-System Pharmacists, March 2003 Reviewer, Hyperlipidemia and Hypertension chapters in the ASHP Therapeutics Review PharmPrep, May 2000 Reviewer, 11th Edition of the American Pharmaceutical Association Handbook of Nonprescription Drugs, March-August 1995 Member, Editorial Advisory Board, "Outpatient Drug Criteria and Outcomes," a newsletter for pharmacists, American Health Consultants of Atlanta, Georgia, February 1995-July 1995 Reviewer, 10th Edition of the American Pharmaceutical Association Handbook of Nonprescription Drugs, 1992-93 Reviewer, Appleton and Krofts Publishing Company, 1986-87 Reviewer, Drug Intelligence and Clinical Pharmacy, 1983-84 and 1990-91 Reviewer, Clinical Pharmacy, 1983-84

Activities with the Pharmaceutical Industry

Continuing Education Provider, LEAD (Leaders in Education and Advancement in Diabetes) Program, sponsored by Aventis Pharmaceuticals, September 2001-December 2002 Member, National Baycol Clinical Pharmacy Advisory Board, March 2000-June 2001

Activities as a Student

Class Coordinator, Doctor of Pharmacy Program, University of Texas Health Science Center at San Antonio, 1982

Page 43: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 43

Regent, Kappa Psi Pharmaceutical Fraternity, School of Pharmacy, Auburn University, Auburn, Alabama, 1980-81 Class Justice, Honor Board, School of Pharmacy, Auburn University, 1980-81 Class Representative, Pharmacy Student Council, School of Pharmacy, Auburn University, 1980-81 Co-Chairman, Campus-wide Red Cross Blood Drive, Auburn University, Auburn, Alabama, 1980 Advisor to Freshman Students, University of Alabama, Tuscaloosa, Alabama, 1978

HONORS, AWARDS, SCHOLARSHIPS, AND RECOGNITIONS

Academic Winner, Award for Excellence in Assessment, American Association of Colleges of Pharmacy, 2012 for the following work: “Incremental Development of an Integrated Assessment Method For the Professional Curriculum” as a team member with Melissa Medina, Nancy Letassy, Vincent Dennis, Ryan Webb, Don Harrison, Mark Stratton, Roger Hornbrook, Ann Lloyd, Patrick Medina, Tracy Hagemann, Michael McShan, Alice Kirkpatrick, Nancy Burgett, Shannan Wideman, JoLaine Draugalis Winner, Innovations in Teaching Competition, American Association of Colleges of Pharmacy, 2007 for the following work: “Using Team-Based Learning as an Instructional Strategy for Teaching an Endocrine Module for Third Year Pharmacy Students Across Two Campuses” as a team member with Nancy Letassy, Melissa Medina, Jeff Stroup, Susan Fugate, Roger Hornbrook, Tom Pento, and Gordon Sachdev Finalist, Teaching Excellence Award, University of Oklahoma College of Pharmacy, April 2003 Nominee, Teaching Excellence Award, University of Oklahoma College of Pharmacy, April 2000, April 2001, April 2002, April 2003, April 2004, April 2005 Nominee, Outstanding Faculty Preceptor, University of Oklahoma College of Pharmacy, March 2002, March 2003 Searle Fellowship in Pharmacy Faculty Mentor Award, Second Place National Award for mentoring Laura McAnally, Pharm.D. student, in writing the essay “Ambulatory Care: A New Frontier for Clinical Pharmacy Practice,” March 1991 Robert G. Leonard Memorial Scholarship, University of Texas at Austin and the University of Texas Health Science Center at San Antonio, 1982-83 Competitive Scholarship, University of Texas at Austin Graduate School, 1981-82 Summa Cum Laude graduate, Auburn University School of Pharmacy, 1981

Page 44: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 44

Phi Kappa Phi, honor society, Auburn University, 1981 Rho Chi, pharmacy honor society, Auburn University School of Pharmacy, 1981 Bristol Award for outstanding contributions and achievements in pursuit of pharmaceutical studies, Auburn University School of Pharmacy, 1981 Jefferson County, Alabama, Award for public and professional relations in pharmacy, Auburn University School of Pharmacy, 1981 Lemmon Award for scholarship, leadership, and character, Auburn University School of Pharmacy, 1981 Merck Award in Medicinal Chemistry, Auburn University School of Pharmacy, 1981 Alumni Award for Excellence in Pharmaceutics, Auburn University School of Pharmacy, 1980 SGA Outstanding Student in the School of Pharmacy, Auburn University, 1980 Alpha Epsilon Delta, pre-medical honorary, University of Alabama, 1977 Alpha Lambda Delta, freshmen honorary, University of Alabama, 1976 Phi Eta Sigma, freshmen honorary, University of Alabama, 1976 National Merit Scholarship Finalist, Greensboro, Alabama, Public School, 1974 Clinical Practice Winner (group award with Nancy Letassy, Vincent Dennis, Todd Marcy, Becky Armor, Micki Hall, Jamie Farley, Heather Edwards, David Hawkins, and Teresa Truong), American Association of Diabetes Educators Pharmacy Community of Interest Pharmacy Best Practices in Diabetes Care Scholarship, August 2012 Fellow, American Society of Health-Systems Pharmacists, March 2012 Innovative Pharmacy Practice Award for the State of Oklahoma (with Nancy Letassy, Pharm.D., C.D.E.), presented by the Oklahoma Pharmacists Association and Elan Biopharmaceuticals, August 2004 Excellence in Anticoagulation Management Award presented by Roche Diagnostics (as a member of the Continuum of Care Clinic, Tinker Air Force Base Outpatient Clinics, Oklahoma City), March 2004 American Diabetes Association recognition of the Pharmacotherapy Diabetes Education Service of the University of Oklahoma Family Medicine Center for meeting the national standards for diabetes self-management education, May 2003 Excellence in Anticoagulation Management Award presented by Roche Diagnostics (as a member of the Pharmacotherapy Service, University of Oklahoma Family Medicine Center), April 2003

Page 45: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 45

Diabetes Care Quality Improvement Award for Outpatient Services, given by the Oklahoma Foundation for Medical Quality (as a member of the Pharmacotherapy Service, University of Oklahoma Family Medicine Center), November 2002 Nominee, AMSUS Award for Excellence in Clinical Pharmacy Practice, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, 1992 and 1993 Unsung Hero Award, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, May 1992 Certificate of Appreciation, Masonic Service Association of the United States, April 1992 Honorary Physician Assistant, presented by the Oklahoma Academy of Physician Assistants, October 1991 Nominee, Andrew Craigie Award, AMSUS Awards, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, 1990 Nominee, Federal Employee of the Year Award offered by the Oklahoma City Federal Executive Council, September 1989 Outstanding Performance Award, Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma, August 1989-95 Outstanding Young Men of America, 1986

CURRENT PROFESSIONAL AFFILIATIONS

American Association of Colleges of Pharmacy American Society of Health-System Pharmacists Auburn Pharmacy Alumni Association Kappa Psi Pharmaceutical Fraternity Oklahoma Pharmacists Association

COMMUNITY SERVICE AND ACTIVITIES

Elder, First Presbyterian Church of Edmond, January 2018 to present Certified Spiritual Director, May 2015 to present Supply Pastor, United Presbyterian Church of Shawnee, Oklahoma, January 2009-May 2010 Stephen Leader, First Presbyterian Church of Edmond, August 2001-April 2010 Stephen Minister, First Presbyterian Church of Edmond, March 1998-April 2010

Page 46: Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP …Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 2 . PROFESSIONAL EXPERIENCE . Academic . Assistant

Curriculum Vitae, August 2019 Mark L. Britton, PharmD, MDiv, CDE, BC-ADM, FASHP page 46

Member, First Presbyterian Church of Edmond, 1991-present Moderator, Oklahoma Presbyterian Cursillo #28, October 2003 Music Coordinator, Oklahoma Presbyterian Cursillo Council, November 2002-December 2004 Moderator, Board of Deacons, First Presbyterian Church of Edmond, June 2000-June 2001 Teacher, Doing a New Thing Sunday School Class, First Presbyterian Church of Edmond, August 2018 to present Teacher, Cornerstone Sunday School Class, First Presbyterian Church of Edmond, August 1999-May 2004 Staff Member, Indiana Presbyterian Cursillo #1, October 1998 Deacon, First Presbyterian Church of Edmond, June 1998-June 2001 Staff Member, Oklahoma Presbyterian Cursillo/Pilgrimage #11, #12, #15, #18, #24, #26, #27, #28 (elected as moderator), #31, #36, #49 (served as spiritual advisor) March 1997-March 2013